Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04644211
Title Ruxolitinib in Thrombocythemia and Polycythemia Vera
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

polycythemia vera

essential thrombocythemia

Therapies

Ruxolitinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST